Corticosteroids are potent anti-inflammatory agents with longstanding use in osteoarthritis treatment, but their effectiveness and safety are unclear. This article summarizes the results of a recent
ated the association of intraarticular corticosteroids with benefits and harms compared with sham injection or no intervention in patients with knee osteoarthritis.
Summary of Findings
Use of intra-articular corticosteroids was associated with a larger pain reduction than control (standardized mean difference [SMD] , −0.40 [95% CI, −0.58 to −0.22]), which corresponds to a difference in pain scores of 1.0 cm on a 10-cm visual analog scale between corticosteroids and control. This effect size corresponds to a number needed to treat of 8 (95% CI, 6 to 13), meaning that for every 8 patients treated with corticosteroids rather than sham injection or no intervention, 1 patient will respond to treatment. The Figure shows random-effects meta-analyses by follow-up time and trial size.
Overall, corticosteroids were associated with a moderate benefit at 1 to 2 weeks after treatment (SMD, −0.48 [95% CI, −0.70 to −0.27]).
The magnitude of this beneficial association decreased with increasing length of follow-up. There was no association of intra-articular steroids withbenefitat6-monthfollow-up(SMD,−0.07[95%CI,−0.25to0.11]). When the meta-analysis was stratified by trial size, results from small trials were similar to the overall analysis. However, associations of intraarticularsteroidswithbenefitwerelessstronginthe3moderatetolarge trials that included 50 patients or more per trial group.
A test for interaction between trial size and treatment effect was positive (P = .01), suggesting small study effects. Findings were similar for physical function. Only 1 of these moderate to large trials that included a total of 100 patients reported adequate concealment of allocation, adequate measures to blind patients, and an intentionto-treat analysis. 2 This trial 2 included exercise therapy as a concomitant treatment in all patients, compared corticosteroid injection with sham injection, included only patients with local signs of inflammation, and used ultrasound guidance to ensure adequate intraarticular placement of needles when injecting a single dose of 40 mg of methylprednisolone acetate. This trial did not find evidence that corticosteroids were associated with clinical benefits after follow-up of 2 weeks, 3 months, and 6 months. 2 The other 2 moderate to large trials compared corticosteroids plus viscosupplementation vs viscosupplementation only or corticosteroids plus joint lavage vs joint lavage only. Only 2 trials contributed to the random-effects meta-analyses of adverse events, withdrawal due to adverse events, and serious adverse events.Therewasnoassociationofcorticosteroidswithadverseevents; however, the 95% CIs were wide and could not exclude the possibility of harm. One small trial found no evidence that intra-articular corticosteroids were associated with joint space narrowing. 1 
Discussion
Intra-articular corticosteroids may be associated with moderate improvement in pain and a small improvement in physical function. However, the quality of evidence is low. Associations of intra-articular steroids with benefit decreased over time. There was no association of intra-articular steroids with benefit at 6-month follow-up.
Limitations
First, the quality of the evidence was generally low, there was considerableheterogeneityamongtrials,andtherewasevidenceofsmallstudy effects. Heterogeneity estimates and associations with benefit decreased when analyses were restricted to trials with appropriate concealment of allocation, nonindustry funding, moderate to large sample BOTTOM LINE Intra-articular corticosteroids may be associated with moderate improvement in pain and a small improvement in physical function up to 6 weeks after injection. However, the quality of the evidence is low. a To derive from standardized mean differences, a probability of treatment response in the control group of 31% was assumed, with response defined as 50% or greater decrease in pain from baseline. 1 The ϱ symbol reported for the point estimate or 95% CI of the number needed to treat (NNT) indicates that the corresponding estimate was in favor of control (ie, the risk difference used to generate the NNT, which is the inverse of the risk difference, was negative, indicating that patients in the control group were more likely to respond to treatment than those receiving corticosteroids). b Trials assessed pain using self-reported instruments such as a 10-cm visual analog scale. c Included 50 or more patients per trial group.
